CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will celebrate a novel technology and recognize up to four key individuals and/or teams who contributed to the […]
Day: November 29, 2022
Nominations Open for the Merkin Prize in Biomedical Technology
CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will celebrate a novel technology and recognize up to four key individuals and/or teams who contributed to the […]
Nominations Open for the Merkin Prize in Biomedical Technology
CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will celebrate a novel technology and recognize up to four key individuals and/or teams who contributed to the […]
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets developed by world-leading teams in therapeutic areas with high unmet need Paris, France, November 29th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to […]
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets developed by world-leading teams in therapeutic areas with high unmet need Paris, France, November 29th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to […]
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets developed by world-leading teams in therapeutic areas with high unmet need Paris, France, November 29th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to […]